Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 9.51 as of Wednesday, July 29, 2026.
Forward PE Ratio (9.51) = Close Price ($13.89) / Consensus Forward EPS ($1.42)
FORWARD PE RATIO
9.51
SECTOR MEDIAN · HEALTHCARE
18.88
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-49.62%
vs the sector median at left
DENTSPLY SIRONA Inc.
Market Cap
$2.78B
Forward PE Ratio
9.51
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| DENTSPLY SIRONA Inc. (XRAY) | $2.78B | 9.51 |
| TransMedics Group, Inc. (TMDX)vs › | $2.60B | 42.75 |
| Teladoc Health, Inc. (TDOC)vs › | $1.69B | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $504.98M | N/A |
| NRC Health (NRC)vs › | $465.83M | 25.39 |
| 23andMe Holding Co. (ME)vs › | $15.31M | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.25B | N/A |
| Tempus AI, Inc. (TEM)vs › | $7.37B | N/A |
| Oscar Health, Inc. (OSCR)vs › | $7.96B | 28.77 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.96B | 36.61 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
9.5
consensus next-FY EPS
At today's $13.89 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $1.42 | $1.40 – $1.44 | 12 | 9.8x |
| 2027-12-31 | $1.55 | $1.47 – $1.65 | 12 | 8.9x |
| 2028-12-31 | $1.71 | $0.22 – $2.86 | 6 | 8.1x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
